CAS: 124900-72-7

YM17E is an inhibitor of ACAT with IC50 of 44 nM in rabbit liver microsomes in vitro.

YM17E is an antifungal antibiotic produced by the fermentation of a specific strain of the bacterium Streptomyces. This natural source has been optimized to create a compound with a potent mode of action that disrupts fungal cell wall synthesis, ultimately leading to cell lysis and death. YM17E functions by targeting the biosynthesis of critical cell wall components, thereby exerting its fungicidal effects through inhibition of essential enzymatic pathways. The applications of YM17E are primarily centered around its use as a research tool in microbiology and mycology to study fungal growth and inhibition. Additionally, its broad-spectrum activity against various pathogenic fungi makes it invaluable in developing new antifungal treatments. The compound's unique mechanism of action provides insight into novel therapeutic approaches and contributes to overcoming resistance in current antifungal therapies. The specificity and efficacy of YM17E make it an important subject of study for advancing antifungal agents.

YM17E